Reducing Friction in CAR T Care: Patient Support for Speed, Scale and Better Outcomes
At the Asembia 2026 Summit, Syneos Health host Chris Van Denburg sits down with Dale Lippert, Executive Director, CAR T Patient Support and Services at Autolus Therapeutics, to explore the operational realities behind CAR T patient support programs for relapsed/refractory acute lymphoblastic leukemia (ALL). Drawing on decades of experience launching CAR T therapies, Dale shares practical insights into how organizations can design patient support models that reduce delays, improve coordination and strengthen the patient and caregiver experience.
The conversation examines the trade-offs between outside hub models and internal hub-and-spoke approaches, including considerations around scalability, governance, flexibility, data visibility and operational readiness. Dale also outlines why many organizations are moving toward hybrid models that balance outsourced administrative support with in-house management of high-risk escalations, site relationships and cross-functional coordination.
Listeners will also hear how effective CAR T patient support programs are built around urgency, transparency and continuous communication. From benefits verification and scheduling coordination to manufacturing logistics and caregiver readiness, Dale explains why reducing friction across every step of the patient journey can have a meaningful impact on treatment timelines and patient outcomes.
The views expressed in this podcast belong solely to the speakers and do not represent those of their organization.
Like what you’re hearing? Find the full Conversations on Commercialization podcast stream here. Also available anywhere you listen to podcasts.
Be sure to rate and review us!
We want to hear from you! If there’s a topic you’d like us to cover on a future episode, contact us at [email protected].
Related Content
Looking for exclusive insight?
